We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+14.05%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$304M
AUM Growth
-$18.2M
Cap. Flow
-$42.9M
Cap. Flow %
-14.12%
Top 10 Hldgs %
58.5%
Holding
65
New
11
Increased
20
Reduced
14
Closed
16

Top Buys

Rank Stock Value
1
INDI icon
indie Semiconductor
INDI
+$11.8M
2
ASPN icon
Aspen Aerogels
ASPN
+$11.4M
3
CMBM
Cambium Networks
CMBM
+$11.4M
4
SCPH
scPharmaceuticals
SCPH
+$11M
5
BDSX icon
Biodesix
BDSX
+$8.28M

Top Sells

Rank Stock Value
1
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$28.3M
2
MTRN icon
Materion
MTRN
+$19.3M
3
SEV
Sono Group N.V. Common Shares
SEV
+$8.93M
4
SIMO icon
Silicon Motion
SIMO
+$7.46M
5
ICAD
iCAD Inc
ICAD
+$3.69M

Sector Composition

Rank Sector Weight
1 Technology 46.84%
2 Healthcare 42.77%
3 Industrials 5.51%
4 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COYA icon
26
Coya Therapeutics
COYA
$107M
$2.65M 0.87%
+560,000
New +$2.61M
RFIL icon
27
RF Industries
RFIL
$142M
$2.61M 0.86%
508,297
-3,740
-0.7% -$19.7K
LPTH icon
28
Lightpath Technologies
LPTH
$754M
$2.48M 0.82%
2,029,832
-10,000
-0.5% -$11.3K
IPWR icon
29
Ideal Power
IPWR
$70.1M
$2.28M 0.75%
213,068
-300
-0.1% -$3.38K
OSA
30
DELISTED
ProSomnus, Inc. Common Stock
OSA
$2.13M 0.7%
+390,640
New +$2.21M
RVLP
31
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$2.02M 0.66%
1,801,864
+1,062,333
+144% +$1.69M
ABEO icon
32
Abeona Therapeutics
ABEO
$393M
$2.01M 0.66%
652,174
+511,530
+364% +$1.91M
MDNA
33
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$1.99M 0.66%
4,346,983
+496,829
+13% +$303K
TFFP
34
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$1.83M 0.6%
+69,565
New +$3.3M
FKWL icon
35
Franklin Wireless
FKWL
$26.8M
$1.74M 0.57%
390,000
– –
VCNX
36
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$1.66M 0.55%
11,675
+1,762
+18% +$218K
CLRB icon
37
Cellectar Biosciences
CLRB
$20.1M
$1.59M 0.53%
31,063
+25,249
+434% +$1.51M
CGRN
38
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$1.3M 0.43%
896,500
-3,500
-0.4% -$6.03K
BCDA icon
39
BioCardia
BCDA
$14.1M
$1.24M 0.41%
+39,682
New +$1.13M
DFSC
40
DEFSEC Technologies
DFSC
$3.28M
$1.03M 0.34%
+1,905
New +$1.09M
SLNO
41
DELISTED
Soleno Therapeutics
SLNO
$837K 0.28%
422,489
-1,600
-0.4% -$1.99K
CNTX icon
42
Context Therapeutics
CNTX
$46.3M
$745K 0.25%
1,143,745
-148,026
-11% -$159K
ADVM
43
DELISTED
Adverum Biotechnologies
ADVM
$695K 0.23%
120,000
– –
DFSCW
44
CALL
DEFSEC Technologies Warrant
DFSCW
$539K 0.18%
+599,000
New +$540K
PCSA icon
45
Processa Pharmaceuticals
PCSA
$6.37M
$334K 0.11%
607
– –
NLSPW
46
CALL
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$240K 0.08%
826,921
+632,861
+326% +$112K
CYTHW
47
CALL
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$141K 0.05%
270,274
+196,538
+267% +$116K
SVREW
48
CALL
SaverOne 2014 Ltd Warrant
SVREW
$56.8K 0.02%
569,194
+427,830
+303% +$85.9K
RZLT icon
49
Rezolute
RZLT
$453M
$24.6K 0.01%
11,866
– –
ARDX icon
50
Ardelyx
ARDX
$1.2B
– –
-1,487,476
Closed -$1.77M
1
2
3

Similar funds

GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
CT
Colonial Trust Spartanburg, South Carolina $735M AUM 18% 1-Year Est. Return
TWP
TFO Wealth Partners Maumee, Ohio $735M AUM 21.07% 1-Year Est. Return
QI
Qtron Investments Boston, Massachusetts $738M AUM 32.56% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return

AIGH Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, AIGH Capital Management held 65 positions worth $304M, down 5.7% from $322M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

AIGH Capital Management withdrew a net $42.9M in Q4 2022, closing 16 positions and reducing 14 holdings. Its most notable exit was Materion, an estimated $19.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 38% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AIGH Capital Management opened a new position in Aspen Aerogels worth $11.8M.

  • AIGH Capital Management's largest Q4 2022 buy was Aspen Aerogels: 1,000,000 shares worth $11.8M.
  • AIGH Capital Management added most to indie Semiconductor in Q4 2022, an estimated $11.8M increase.
  • AIGH Capital Management's biggest Q4 2022 reduction was AVEO Pharmaceuticals, Inc., cutting an estimated $28.3M.
  • AIGH Capital Management fully exited Materion in Q4 2022, selling an estimated $19.3M.
  • AIGH Capital Management's ten largest holdings make up 59% of its $304M portfolio in Q4 2022.
  • AIGH Capital Management opened 11 new positions and closed 16 in Q4 2022.
  • AIGH Capital Management's portfolio value fell 5.7% quarter-over-quarter to $304M.

Based on AIGH Capital Management's 13F filing for Q4 2022, filed 15 Feb 2023.